New regulatory application for MS cannabis spray Sativex®

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

New regulatory application for MS cannabis spray Sativex®

Postby MSUK » Sun Jul 21, 2013 11:49 pm

New regulatory application for MS cannabis spray Sativex® approval in France
GW Pharmaceuticals plc announced that it has submitted an application under the European Mutual Recognition Procedure (MRP) seeking to expand the marketing authorisation for Sativex® into France for the treatment of spasticity due to Multiple Sclerosis (MS).

This new regulatory application follows a Decree signed by the French Minister of Health in June 2013, which amended national legislation in France so as to permit a prescription cannabis-based medicine, subject to approval by ANSM, the French regulatory authority. As with previous Sativex MRP filings, the UK regulatory authority, the Medicines and Healthcare products Regulatory Agency (MHRA), is acting as the Reference Member State.... Read More - http://www.ms-uk.org/index.cfm/sativex
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2211
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Re: New regulatory application for MS cannabis spray Sativex

Postby ton » Mon Jul 22, 2013 3:02 pm

ANYONE HAS INFORMATION ABOUT APPROVAL IN ARGENTINA?
User avatar
ton
Family Member
 
Posts: 34
Joined: Thu May 27, 2010 2:00 pm


Return to Sativex

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service